This CME series discusses adopting ACOG and SMFM guidance for the use of diagnostic tests, such as fetal fibronectin, the proper use of fetal fibronectin, the importance of patient history, and risk factors to decrease the likelihood of preterm labor and birth.
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
